- ￥1872 - 6669
- Biorbyt
- orb2977909
- 英国
- 2026年08月07日
- ELISA, FA, FACS, In vivo
- Human Humanized
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AJE 润色服务限时 8 折起，权威机构信任 15+ 年Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
Risankizumab Human Monoclonal Antibody 抗体
- 抗体英文名：
Risankizumab Human Monoclonal Antibody
- 靶点：
SGRF, IL-23-A, IL-23 subunit alpha, Interleukin-23 subunit p19, IL23A, Interleukin-23 subunit alpha, IL-23p19
- 浓度：
Lot dependent
- 应用范围：
ELISA, FA, FACS, In vivo
- 宿主：
Human Humanized
- 适应物种：
Human
- 保质期：
12 months from date of receipt.
- 抗原来源：
详询
- 目录编号：
orb2977909
- 级别：
科研
- 库存：
99
- 供应商：
Biorbyt
- 标记物：
Unconjugated
- 克隆性：
Monoclonal
- 保存条件：
详询
- 形态：
Liquid
- 亚型：
IgG1-kappa
- 免疫原：
详询
- 规格：
100 ug/1 mg
| 规格： | 100 ug | 产品价格： | ￥1872.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥6669.0 |
产品子类型: Biosimilar Antibody
描述: Risankizumab Human Monoclonal Antibody is an unconjugated monoclonal antibody. It shows reactivity with Human samples. It is suitable for use in ELISA, FA, FACS, In vivo applications. The antibody is supplied in liquid form. It is Protein A/G purified from cell culture supernatant. Purity is >95% purity as determined by SDS-PAGE.
内毒素: Please contact the lab for this information.
表达系统: Mammalian Cells
防腐剂: 0.01M PBS, pH 7.4.
纯度: >95% purity as determined by SDS-PAGE.
纯化方法: Protein A/G purified from cell culture supernatant.
保存条件: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
备注: For research use only.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Human Monoclonal Antibodies: The Residual Challenge of Antibody Immunogenicity
One of the major reasons for seeking human monoclonal antibodies has been to eliminate immunogenicity seen with rodent antibodies. Thus far, there has yet been no approach which absolutely abolishes that risk for cell-binding antibodies
Generation of a Monoclonal Antibody Library Against Human Embryonic Stem Cells
Differentiated cell types derived from human embryonic stem cells (hESCs) may serve in the future to treat various human diseases and to model early human embryonic development in vitro. Fulfilling this potential, however, requires extensive
patterns rather than individual protein markers. The development of an antibody microarray platform of general applicability requires careful consideration of the array content. The human cluster of differentiation (CD) antigens constitute a promising
技术资料暂无技术资料 索取技术资料
